Shuttle Pharmaceuticals corrects pre-funded warrants issued to 9,741,751 shares as of Sept. 9
SHPH•Shuttle Pharmaceuticals amended a Sept. 15 Form 8-K to report that 9,741,751 pre-funded warrants had been issued as of Sept. 9, 2026, correcting an earlier disclosure of up to 16,932,508.
1. Corrected warrant disclosure
Shuttle Pharmaceuticals amended its Sept. 15 Form 8-K to correct its disclosure on pre-funded warrants issued under Item 3.02. The earlier filing cited up to 16,932,508 warrants, the maximum that could be issued if all conditions were met; the company said 9,741,751 had actually been issued as of Sept. 9, 2026.
